New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 20, 2020 - Micro Labs, Viatris, Zydus, Solco, Novadoz/MSN, and Camber launched AB-rated generic versions of AstraZeneca’s Daliresp (roflumilast) 500 mcg tablets.
Download PDF
Return to publications
